Clinical Trials Browser

Phase 2 × Terminated × Hemangiosarcoma × Clear all

NCT05026736 2025-08-17

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Phase 2 Terminated

Hemangiosarcoma

NCT04996004 2024-12-11

TTI-621-03

Phase 2 Terminated

76 enrolled 53 charts

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

NCT02212015 2022-03-22

EVA

Phase 2 Terminated

26 enrolled 16 charts

Hemangiosarcoma